IMAGE1 (TC400US); X-to-4U Adapter (TC040)
Karl Storz SE & CO. KG · Decision date Feb 12, 2026
What did the FDA decide?
FDA records K253972 as a 510(k) premarket notification, with a decision dated Feb 12, 2026. The decision code SESE records a finding of substantial equivalence. This is a 510(k) clearance.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Gastroenterology, Urology
- Decision date
- Feb 12, 2026
Regulatory record facts
- Identifier
- K253972
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Karl Storz SE & CO. KG
- Product code
- OWN
- Decision code
- SESE
- Decision date
- Feb 12, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Confocal Optical Imaging.
- Applicant
- Karl Storz SE & CO. KG
- Product code
- OWN
- FDA device class
- 2
FDA decision timeline
K253972 received
Application receipt date recorded by FDA.
K253972 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code OWN
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
KARL STORZ TIPCAM1 RubinaK262547 | KALR STORZ SE & Co. KG | 510(k) clearance | Sep 21, 2026 | FDA |
PerfusiX-ImagingK254180 | LIMIS Development B.V. | 510(k) clearance | Jul 24, 2026 | FDA |
| SmartsurgN, Inc. | 510(k) clearance | Apr 20, 2026 | FDA | |
| Karl Storz SE & CO. KG | 510(k) clearance | Feb 26, 2026 | FDA | |
| VPIX MEDICAL, INC. | 510(k) clearance | Feb 13, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Karl Storz SE & CO. KG
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Tuttlingen
Sources and methodology
- Original FDA record: K253972
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 20, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records


